Download PDF
1 / Pages

Other users also viewed these articles

Second Mexican consensus on biologic therapy and small-molecule inhibitors in inflammatory bowel disease J.K. Yamamoto-Furusho; F.J. Bosques-Padilla; M.A. Martínez-Vázquez;
Rev Gastroenterol Mex. 2021;86:70-85
Latin American consensus on the quality indicators for comprehensive care clinics for patients with inflammatory bowel disease: PANCCO-GETECCU J.K. Yamamoto-Furusho; D. Andrade; J. Barahona; S. Bautista; F. Bosques-Padilla; J. de Paula; M.T. Galiano; B. Iade; F. Juliao-Baños; G. Otoya; F. Steinwurz; E. Torres; G. Veitia; M. Barreiro-de Acosta;
Rev Gastroenterol Mex. 2022;87:89-102
Characterization of inflammatory bowel disease in Colombia: Results of a national register F. Juliao-Baños; F. Puentes; R. López; M.A. Saffon; G. Reyes; V. Parra; M.T. Galiano; M. Barraza; J. Molano; E. Álvarez; R. Corrales; L.E. Vargas; F. Gil; P. Álvarez; L. Limas; R. Prieto; P. Yance; F. Díaz; J. Bareño;
Rev Gastroenterol Mex. 2021;86:153-62